Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Schneider, Dietmar (BerichterstatterIn) , Brandt, Tobias (BerichterstatterIn) , Hacke, Werner (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 14 1998
In: European neurology
Year: 1998, Jahrgang: 40, Heft: 2, Pages: 78-83
ISSN:1421-9913
DOI:10.1159/000007962
Online-Zugang:Verlag: https://doi.org/10.1159/000007962
Verlag, Volltext: http://www.karger.com/Article/Pdf/7962
Volltext
Verfasserangaben:D. Schneider ... T. Brandt, W. Hacke ...

MARC

LEADER 00000caa a22000002c 4500
001 149846663X
003 DE-627
005 20250526133403.0
007 cr uuu---uuuuu
008 150401s1998 xx |||||o 00| ||eng c
024 7 |a 10.1159/000007962  |2 doi 
035 |a (DE-627)149846663X 
035 |a (DE-576)42846663X 
035 |a (DE-599)BSZ42846663X 
035 |a (OCoLC)1340676625 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody)  |b an open-label, dose escalation study in patients hospitalized for acute stroke  |c D. Schneider ... T. Brandt, W. Hacke ... 
264 1 |c August 14 1998 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 26.05.2025 
700 1 |a Schneider, Dietmar  |d 1943-  |0 (DE-588)131850563  |0 (DE-627)707752426  |0 (DE-576)25528070X  |4 oth 
700 1 |a Brandt, Tobias  |0 (DE-588)1064032869  |0 (DE-627)812888227  |0 (DE-576)423579487  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
773 0 8 |i In  |t European neurology  |d Basel : Karger, 1968  |g 40(1998), 2, Seite 78-83  |h Online-Ressource  |w (DE-627)300191448  |w (DE-600)1482237-4  |w (DE-576)273865196  |x 1421-9913  |7 nnas  |a Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody) an open-label, dose escalation study in patients hospitalized for acute stroke 
773 1 8 |g volume:40  |g year:1998  |g number:2  |g pages:78-83  |g extent:6  |a Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody) an open-label, dose escalation study in patients hospitalized for acute stroke 
856 4 0 |u https://doi.org/10.1159/000007962  |x Verlag 
856 4 0 |u http://www.karger.com/Article/Pdf/7962  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20150401 
993 |a Article 
994 |a 1998 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 1064032869  |a Brandt, Tobias  |m 1064032869:Brandt, Tobias  |d 910000  |d 911100  |e 910000PB1064032869  |e 911100PB1064032869  |k 0/910000/  |k 1/910000/911100/  |p 3 
999 |a KXP-PPN149846663X  |e 2836901535 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"1998","dateIssuedDisp":"August 14 1998"}],"id":{"doi":["10.1159/000007962"],"eki":["149846663X"]},"name":{"displayForm":["D. Schneider ... T. Brandt, W. Hacke ..."]},"physDesc":[{"extent":"6 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1968","publisher":"Karger","dateIssuedDisp":"1968-","publisherPlace":"Basel"}],"id":{"eki":["300191448"],"zdb":["1482237-4"],"issn":["1421-9913"]},"pubHistory":["1.1968 -"],"part":{"year":"1998","issue":"2","pages":"78-83","text":"40(1998), 2, Seite 78-83","volume":"40","extent":"6"},"note":["Gesehen am 25.04.2019"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody) an open-label, dose escalation study in patients hospitalized for acute strokeEuropean neurology","language":["eng"],"recId":"300191448","title":[{"title_sort":"European neurology","title":"European neurology"}]}],"title":[{"subtitle":"an open-label, dose escalation study in patients hospitalized for acute stroke","title":"Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody)","title_sort":"Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody)"}],"person":[{"role":"oth","display":"Schneider, Dietmar","given":"Dietmar","family":"Schneider"},{"display":"Brandt, Tobias","role":"oth","family":"Brandt","given":"Tobias"},{"display":"Hacke, Werner","role":"oth","family":"Hacke","given":"Werner"}],"note":["Gesehen am: 26.05.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"149846663X","language":["eng"]} 
SRT |a SAFETYPHAR1419